#$%^&*AU2016219615A120160915.pdf#####Abstract Compositions comprising fucan agents and the use of said compositions in the treatment, prevention, inhibition etc, 5 of fibrous adhesions, peritonitis, ischemia, reperfusion injury, endotoxemia, keloids and keloid trait scarring, dermatitis and rosacea. The preferred fucan agents are characterized by their molecular weight distribution. 81087021 (GHMatters) P89657.AU.1 19/08/16